Skip to main content

MARSHALL WACE, LLP

Position in PAHC — Phibro Animal Health Corp

CIK 1318757 LONDON, X0

Position in PAHC

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$340,156
-$37,832 QoQ
Shares Held
10,833
+58.5% QoQ
Ownership
0.027%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#110
of 206 holders
Holding Since
Sep 2020
10 quarters on record
Voting authority Sole 0% Shared 100% None 0%

Common Shares in PAHC Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

MARSHALL WACE, LLP holds $609,159,561 across 30 Drug Manufacturers - Specialty & Generic names. PAHC ranks #26 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in PAHC

Export CSV
10 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $340,156 10,833
2026-03-31 $377,988 6,834
2023-09-30 $437,180 34,235
2022-09-30 $379,682 28,569
2022-06-30 $702,013 36,697
2022-03-31 $1,975,030 98,999
2021-09-30 $268,280 12,455
2021-06-30 $596,054 20,639
2020-12-31 $1,475,492 75,978
2020-09-30 $368,010 21,150